Microcirculatory Changes During Magnesium Sulphate Infusion in Sepsis
Microcirculatory Changes During Open Label Magnesium Sulphate Infusion in Severe Sepsis and Septic Shock
Sponsor: Frisius Medisch Centrum
Listed as NCT01332734, this observational or N/A phase trial focuses on Septic Shock and Severe Sepsis and remains completed. Sponsored by Frisius Medisch Centrum, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Jun 2025 — Present [monthly]
Completed
-
Sep 2024 — Jun 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Apr 2018 — Jan 2021 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Mar 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Frisius Medisch Centrum
- Lithuanian University of Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .